{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:22:48Z","timestamp":1740108168407,"version":"3.37.3"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T00:00:00Z","timestamp":1532044800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00115-018-0565-6","type":"journal-article","created":{"date-parts":[[2018,7,20]],"date-time":"2018-07-20T03:41:52Z","timestamp":1532058112000},"page":"945-957","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["MRT-Ver\u00e4nderungen bei Immunmodulation","MRI alterations in immunomodulation"],"prefix":"10.1007","volume":"89","author":[{"given":"K.","family":"Guggenberger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7264-4807","authenticated-orcid":false,"given":"H.","family":"Urbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,20]]},"reference":[{"key":"565_CR1","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1086\/597126","volume":"199","author":"A Egli","year":"2009","unstructured":"Egli A, Infanti L, Dumoulin A, Buser A, Samaridis J, Stebler C, Gosert R, Hirsch HH (2009) Prevalence of polyomavirus BK and JC infection and replication in 400 healthy blood donors. J\u00a0Infect Dis 199:837\u2013846","journal-title":"J Infect Dis"},{"key":"565_CR2","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1056\/NEJMoa1107829","volume":"366","author":"G Bloomgren","year":"2012","unstructured":"Bloomgren G, Richman S, Hotermans C, Subramanyam M, Goelz S, Natarajan A, Lee S, Plavina T, Scanlon JV, Sandrock A, Bozic C (2012) Risk of natalizumab-associated progressive multifocal leukoencephalopathy. N\u00a0Engl J Med 366:1870\u20131880","journal-title":"N Engl J Med"},{"key":"565_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.msard.2016.03.005","volume":"8","author":"J Borchardt","year":"2016","unstructured":"Borchardt J, Berger JR (2016) Re-evaluating the incidence of natalizumab-associated progressive multifocal leukoencephalopathy. Mult Scler Relat Disord 8:145\u2013150","journal-title":"Mult Scler Relat Disord"},{"key":"565_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008933.pub2","author":"G Filippini","year":"2013","unstructured":"Filippini G, Del Giovane C, Vacchi L, D\u2019Amico R, Di Pietrantonj C, Beecher D, Salanti G (2013) Immunomodulators and immunosuppressants for multiple sclerosis: a\u00a0network meta-analysis. Cochrane Database Syst Rev. \n                    https:\/\/doi.org\/10.1002\/14651858.CD008933.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"565_CR5","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1001\/archneurol.2011.103","volume":"68","author":"DB Clifford","year":"2011","unstructured":"Clifford DB, Ances B, Costello C, Rosen-Schmidt S, Andersson M, Parks D, Perry A, Yerra R, Schmidt R, Alvarez E, Tyler KL (2011) Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis. Arch Neurol 68:1156\u20131164","journal-title":"Arch Neurol"},{"key":"565_CR6","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1212\/WNL.0000000000002654","volume":"86","author":"TV Gyang","year":"2016","unstructured":"Gyang TV et al (2016) Fingolimod-associated PML in a\u00a0patient with prior immunosuppression. Neurology 86:1843\u20131845","journal-title":"Neurology"},{"key":"565_CR7","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1056\/NEJMc1415408","volume":"372","author":"T Rosenkranz","year":"2015","unstructured":"Rosenkranz T, Novas M, Terborg C (2015) PML in a\u00a0patient with lymphocytopenia treated with dimethyl fumarate. N\u00a0Engl J Med 372:1476\u20131478","journal-title":"N Engl J Med"},{"key":"565_CR8","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/j.1468-1331.2006.01362.x","volume":"13","author":"W. Kuker","year":"2006","unstructured":"Kuker W, Mader I, Nagele T, Uhl M, Adolph C, Klose U, Herrlinger U (2006) Progressive multifocal leukoencephalopathy: value of diffusion-weighted and contrast-enhanced magnetic resonance imaging for diagnosis and treatment control. Eur J Neurol 13(8):819\u2013826","journal-title":"Eur J Neurol"},{"key":"565_CR9","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/ana.23676","volume":"72","author":"TA Yousry","year":"2012","unstructured":"Yousry TA, Pelletier D, Cadavid D, Gass A, Richert ND, Radue EW, Filippi M (2012) Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy. Ann Neurol 72:779\u2013787","journal-title":"Ann Neurol"},{"key":"565_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/809252","volume":"2015","author":"Justin M. Honce","year":"2015","unstructured":"Honce JM, Nagae L, Nyberg E (2015) Neuroimaging of natalizumab complications in multiple sclerosis: PML and other associated entities. Mult Scler Int 2015:1\u201314","journal-title":"Mult Scler Int"},{"key":"565_CR11","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1136\/jnnp-2016-313772","volume":"87","author":"MT Wijburg","year":"2016","unstructured":"Wijburg MT, Witte BI, Vennegoor A, Roosendaal SD, Sanchez E, Liu Y, Martins Jarnalo CO, Uitdehaag BM, Barkhof F, Killestein J, Wattjes MP (2016) MRI criteria differentiating asymptomatic PML from new MS lesions during natalizumab pharmacovigilance. J\u00a0Neurol Neurosurg Psychiatr 87:1138\u20131145","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"key":"565_CR12","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1212\/01.wnl.0000341766.59028.9d","volume":"72","author":"BO Khatri","year":"2009","unstructured":"Khatri BO, Man S, Giovannoni G, Koo AP, Lee JC, Tucky B, Lynn F, Jurgensen S, Woodworth J, Goelz S, Duda PW, Panzara MA, Ransohoff RM, Fox RJ (2009) Effect of plasma exchange in accelerating natalizumab clearance and restoring leukocyte function. Neurology 72:402\u2013409","journal-title":"Neurology"},{"key":"565_CR13","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1093\/brain\/awr206","volume":"134","author":"L Aly","year":"2011","unstructured":"Aly L, Yousef S, Schippling S, Jelcic I, Breiden P, Matschke J, Schulz R, Bofill-Mas S, Jones L, Demina V, Linnebank M, Ogg G, Girones R, Weber T, Sospedra M, Martin R (2011) Central role of JC virus-specific CD4+ lymphocytes in progressive multi-focal leucoencephalopathy-immune reconstitution inflammatory syndrome. Brain 134:2687\u20132702","journal-title":"Brain"},{"key":"565_CR14","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1200\/JCO.1986.4.12.1845","volume":"4","author":"RW Walker","year":"1986","unstructured":"Walker RW, Allen JC, Rosen G et al (1986) Transient cerebral dysfunction secondary to high-dose methotrexate. J\u00a0Clin Oncol 4:1845","journal-title":"J Clin Oncol"},{"key":"565_CR15","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1093\/annonc\/mdm466","volume":"19","author":"H Inaba","year":"2008","unstructured":"Inaba H, Khan RB, Laningham FH, Crews KR, Pui CH, Daw NC (2008) Clinical and radiological characteristics of methotrexate-induced acute encephalopathy in pediatric patients with cancer. Ann Oncol 19:178\u2013184","journal-title":"Ann Oncol"},{"key":"565_CR16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3174\/ajnr.A1623","volume":"30","author":"KJ Carpenter","year":"2009","unstructured":"Carpenter KJ, Murtagh RD, Lilienfeld H, Weber J, Murtagh FR (2009) Ipilimumab-induced hypophysitis: MR imaging findings. Ajnr Am J Neuroradiol 30:175","journal-title":"Ajnr Am J Neuroradiol"},{"key":"565_CR17","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s40425-017-0249-y","volume":"5","author":"H L\u00e4ubli","year":"2017","unstructured":"L\u00e4ubli H et al (2017) Cerebral vasculitis mimicking intracranial metastatic progression of lung cancer during PD-1 blockade. J\u00a0Immunother Cancer 5:46","journal-title":"J Immunother Cancer"},{"key":"565_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2016-215012","author":"S Salam","year":"2016","unstructured":"Salam S, Lavin T, Turan A (2016) Limbic encephalitis following immunotherapy against metastatic malignant melanoma. BMJ Case Rep. \n                    https:\/\/doi.org\/10.1136\/bcr-2016-215012","journal-title":"BMJ Case Rep."},{"key":"565_CR19","first-page":"654","volume":"26","author":"JN Campbell","year":"2005","unstructured":"Campbell JN, Morris PP (2005) Cerebral vasculitis in graft-versus-host disease: a\u00a0case report. AJNR Am J Neuroradiol 26:654\u2013656","journal-title":"AJNR Am J Neuroradiol"},{"key":"565_CR20","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1093\/annonc\/mdm420","volume":"18","author":"S Boeck","year":"2007","unstructured":"Boeck S, Wollenberg A, Heinemann V (2007) Leukocytoclastic\u00a0vasculitis\u00a0during treatment with the oral EGFR\u00a0tyrosine kinaseinhibitor\u00a0erlotinib. Ann Oncol 18:1582\u20131583","journal-title":"Ann Oncol"},{"key":"565_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00234-017-1804-4","volume":"59","author":"A Server","year":"2017","unstructured":"Server A, Bargall\u00f3 N, Floisand Y, Sponheim J, Graus F, Hald JK (2017) Imaging spectrum of central nervous system complications og hematopoietic stem cell and solid organ transplantation. Neuroradiology 59:105\u2013126","journal-title":"Neuroradiology"},{"key":"565_CR22","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.clinimag.2017.08.008","volume":"47","author":"Emily Brady","year":"2018","unstructured":"Brady E, Parikh NS, Navi BB, Gupta A, Schweitzer AD (2018) The imaging spectrum of posterior reversible encephalopathy syndrome: A\u00a0pictorial review. Clinical Imaging 47:80\u201389","journal-title":"Clinical Imaging"},{"key":"565_CR23","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1148\/radiology.216.2.r00au24363","volume":"216","author":"LA Loevner","year":"2000","unstructured":"Loevner LA, Karpati RL, Kumar P et\u00a0al (2000) Posttransplantation lymphoproliferative disorder of the head and neck: imaging features in seven adults. Radiology 216:363\u2013369","journal-title":"Radiology"},{"key":"565_CR24","first-page":"1695","volume":"26","author":"KC Brennan","year":"2005","unstructured":"Brennan KC, Lowe LH, Yeaney GA (2005) Pediatric central nervous system posttransplant lymphoproliferative disorder. Am J Neuroradiol AJNR 26:1695\u20131697","journal-title":"Am J Neuroradiol AJNR"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-018-0565-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-018-0565-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-018-0565-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T19:28:39Z","timestamp":1563564519000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-018-0565-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,20]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["565"],"URL":"https:\/\/doi.org\/10.1007\/s00115-018-0565-6","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"type":"print","value":"0028-2804"},{"type":"electronic","value":"1433-0407"}],"subject":[],"published":{"date-parts":[[2018,7,20]]},"assertion":[{"value":"20 July 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"K.\u00a0Guggenberger und H.\u00a0Urbach geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}